CN102274334A - Medicine for treating rhinitis and preparation method thereof - Google Patents

Medicine for treating rhinitis and preparation method thereof Download PDF

Info

Publication number
CN102274334A
CN102274334A CN2011102694795A CN201110269479A CN102274334A CN 102274334 A CN102274334 A CN 102274334A CN 2011102694795 A CN2011102694795 A CN 2011102694795A CN 201110269479 A CN201110269479 A CN 201110269479A CN 102274334 A CN102274334 A CN 102274334A
Authority
CN
China
Prior art keywords
medicine
parts
rhinitis
flos
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011102694795A
Other languages
Chinese (zh)
Inventor
吴晓娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lucheng Jiuding Health-Care Product Co Ltd
Original Assignee
Lucheng Jiuding Health-Care Product Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lucheng Jiuding Health-Care Product Co Ltd filed Critical Lucheng Jiuding Health-Care Product Co Ltd
Priority to CN2011102694795A priority Critical patent/CN102274334A/en
Publication of CN102274334A publication Critical patent/CN102274334A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating rhinitis and a preparation method thereof. The medicine is prepared by using honeysuckle flower, phellodendron chinense schneid, weeping forsythia, mint, angelica dahurica, biond magnolia flower, chrysanthemum, asarum and liquoric root as raw materials. The medicinal can be formed into various formulations used in clinic. In the formula of the invention, the medicines are mixed reasonably to produce effects of clearing heat, detoxifying, clearing away heat, eliminating dampness and clearing throat, so the medicine for treating rhinitis has a good treatment effect on diseases such as allergic rhinitis, rhinitis chronic and chronic sinusitis. The result of a clinic test proves the medicine has obvious effect, is free from toxic and side effect and can be used safely and reliably in clinic.

Description

A kind of medicine for the treatment of rhinitis and preparation method thereof
Technical field
The present invention relates to a kind of medicine for the treatment of rhinitis, specially referring to a kind of is the medicine of the treatment rhinitis of feedstock production with the Chinese herbal medicine, the invention still further relates to the preparation method of this medicine.
Background technology
In recent years, along with the change of people life style and dietary structure, rhinitis becomes a kind of frequently-occurring disease in some areas.Rhinitis be since acute or chronic nasal mucosa as virus, courses of infection, or impaired causing under the effect of stimulus object.Rhinitis causes producing too much mucus, causes symptoms such as watery nasal discharge, nasal obstruction usually, and long-term rhinitis can cause tremendous influence to health, and by nearest studies show that of the U.S., surpassing 5,000 ten thousand Americans is rhinitis patients.Rhinitis does not singly just influence nose, also can influence throat and eyes simultaneously.It also can influence people's sleep quality, audition and learning capacity, should cause enough attention.
At present the Western medicine of treatment rhinitis is a lot, is antibiotic medicine a lot, takes for a long time, makes the people strengthen dependency to medicine easily, and the organ of taking for a long time the intestines and stomach of human body has very big side effect.
The traditional Chinese medical science has its unique effect to the treatment of this disease, and the traditional Chinese medical science thinks, clinically often is divided into asthenia of pulmonosplenic qi type and stagnation of QI type of stagnation of blood according to symptom.Asthenia of pulmonosplenic qi type main symptom: heavy when light during nasal obstruction, nasal mucus is rare clearly, meets cold increasing the weight of, hyposmia, headache, dizziness.Inspection sees that intranasal swelling color is light.Insufficiency of lung-QI person is double to see the cough thin sputum, and complexion (white light) is white, pale tongue with white fur, moderate pulse or heavy thin.The deficiency of spleen-QI person is double to be seen and is off one's feed fatigue and asthenia, pale tongue, Tai Bai or thick, relaxed and soft pulse.Qi stagnation blood stasis type main symptom: the nasal obstruction time is long, and nasal mucus is many, and sticking yellow or sticking white, baryo,dmia is checked and seen intranasal swelling, is the Fructus Mori sample.
Summary of the invention
The present invention aims to provide that a kind of therapeutic effect is good, cost is low, the medicine of the medicine of the treatment rhinitis of non-evident effect and preparation method thereof.
The preparation method that this medicine is provided is another goal of the invention of the present invention.
Medicine of the present invention is to be made by following quality proportion raw material:
Flos Lonicerae 10-15 part, Cortex Phellodendri 6-11 part, Fructus Forsythiae 10-15 part, Herba Menthae 3-6 part, Radix Angelicae Dahuricae 5-8 part, Flos Magnoliae 3-6 part, Flos Chrysanthemi 7-12 part, Herba Asari 4-6 part, Radix Glycyrrhizae 3-6 part.
The further quality proportioning of medicine each component of the present invention is:
12 parts of Flos Loniceraes, 9 parts of Cortex Phellodendris, 12 parts of Fructus Forsythiaes, 5 parts of Herba Menthaes, 6 parts of the Radixs Angelicae Dahuricae, 5 parts of Flos Magnoliaes, 8 parts of Flos Chrysanthemis, 5 parts of Herba Asaris, 5 parts in Radix Glycyrrhizae.
Medicine of the present invention can be made said dosage form on any pharmaceutics, is preferred dosage form here with the capsule.
The concrete preparation method of medicine of the present invention is as follows:
With above-mentioned various medicines according to described ratio of weight and number mix homogeneously after, decoct with water 3 times, each 0.5~1 hour, merge 3 times decocting liquid, filter, be condensed into 60 ℃ of relative densities and be 1.25~1.3 thick paste, after 50~60 ℃ of dryings, be crushed to 100~120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
In the medicine of the present invention:
The Flos Lonicerae sweet in the mouth, cold in nature, have the effect of heat-clearing and toxic substances removing, dispelling wind and heat pathogens.Flos Lonicerae has heat-clearing and toxic substances removing, dredges the effect of throat, the relieving restlessness of relieving summer heat.
Cortex Phellodendri is the dry bark of rutaceae wampee, functions such as tool heat-clearing and toxic substances removing, pathogenic fire purging dampness
The Fructus Forsythiae heat-clearing and toxic substances removing cures mainly calentura from the beginning of, anemopyretic cold, and heating is vexed, laryngopharynx swelling and pain, acute nephritis etc.
Chrysanthemum powder forimproving wind heat-clearing and toxic substances removing, suppressing the hyperactive liver makes eye bright.Be used for anemopyretic cold, it is dizzy to have a headache, conjunctival congestion and swelling pain, and eyes is dim-sighted.
In the prescription of the present invention, all medicine compatibilities are reasonable, can heat-clearing and toxic substances removing, pathogenic fire purging dampness, dredge throat, diseases such as allergic rhinitis, chronic rhinitis, chronic sinusitis are had curative effect preferably.
During treatment, this medicine was taken for three times morning, noon, the late branch.
Use clinical drug treatment of allergic rhinitis patient 100 examples of the present invention (1 week was 1 course of treatment), chronic rhinitis 150 examples (2 weeks were 1 course of treatment), chronic sinusitis 150 examples (2 weeks were 1 course of treatment), its 1 course cure rate is respectively 89%, 86%, 91%, total effective rate is respectively 96%, 94%, 98%, and clinical test results proves that effect of drugs of the present invention obviously, definitely, and have no side effect, clinical practice is safe and reliable.
The specific embodiment
Below in conjunction with embodiment the present invention is described in further detail, but does not constitute any limitation of the invention.
Embodiment 1
Prepare raw material according to following weight:
Flos Lonicerae 12kg, Cortex Phellodendri 9 kg, Fructus Forsythiae 12 kg, Herba Menthae 5 kg, the Radix Angelicae Dahuricae 6 kg, Flos Magnoliae 5 kg, Flos Chrysanthemi 8 kg, Herba Asari 5 kg, Radix Glycyrrhizae 5 kg.
With above-mentioned various medicines according to described ratio of weight and number mix homogeneously after, decoct with water 3 times, each 0.5~1 hour, merge 3 times decocting liquid, filter, be condensed into 60 ℃ of relative densities and be 1.25~1.3 thick paste, after 50~60 ℃ of dryings, be crushed to 100~120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
Embodiment 2
Prepare raw material according to following weight:
Flos Lonicerae 14 kg, Cortex Phellodendri 6 kg, Fructus Forsythiae 10 kg, Herba Menthae 4 kg, the Radix Angelicae Dahuricae 7 kg, Flos Magnoliae 3 kg, Flos Chrysanthemi 7 kg, Herba Asari 4 kg, Radix Glycyrrhizae 3 kg.
With above-mentioned various medicines according to described ratio of weight and number mix homogeneously after, decoct with water 3 times, each 0.5~1 hour, merge 3 times decocting liquid, filter, be condensed into 60 ℃ of relative densities and be 1.25~1.3 thick paste, after 50~60 ℃ of dryings, be crushed to 100~120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.

Claims (4)

1. medicine for the treatment of rhinitis is characterized in that described medicine is to be made by following quality proportion raw material:
Flos Lonicerae 10-15 part, Cortex Phellodendri 6-11 part, Fructus Forsythiae 10-15 part, Herba Menthae 3-6 part, Radix Angelicae Dahuricae 5-8 part, Flos Magnoliae 3-6 part, Flos Chrysanthemi 7-12 part, Herba Asari 4-6 part, Radix Glycyrrhizae 3-6 part.
2. the medicine of treatment rhinitis according to claim 1 is characterized in that described medicine is to be made by following quality proportion raw material:
12 parts of Flos Loniceraes, 9 parts of Cortex Phellodendris, 12 parts of Fructus Forsythiaes, 5 parts of Herba Menthaes, 6 parts of the Radixs Angelicae Dahuricae, 5 parts of Flos Magnoliaes, 8 parts of Flos Chrysanthemis, 5 parts of Herba Asaris, 5 parts in Radix Glycyrrhizae.
3. the medicine of treatment rhinitis according to claim 1 and 2 is characterized in that described medicine is made capsule.
4. the preparation method of the medicine of the described treatment rhinitis of claim 3, be with above-mentioned various medicines according to described ratio of weight and number mix homogeneously after, decoct with water 3 times, each 0.5~1 hour, merge 3 times decocting liquid, filter, be condensed into 60 ℃ of relative densities and be 1.25~1.3 thick paste, after 50~60 ℃ of dryings, be crushed to 100~120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
CN2011102694795A 2011-09-13 2011-09-13 Medicine for treating rhinitis and preparation method thereof Pending CN102274334A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102694795A CN102274334A (en) 2011-09-13 2011-09-13 Medicine for treating rhinitis and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102694795A CN102274334A (en) 2011-09-13 2011-09-13 Medicine for treating rhinitis and preparation method thereof

Publications (1)

Publication Number Publication Date
CN102274334A true CN102274334A (en) 2011-12-14

Family

ID=45100279

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102694795A Pending CN102274334A (en) 2011-09-13 2011-09-13 Medicine for treating rhinitis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN102274334A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524100A (en) * 2014-12-11 2015-04-22 广东聚智诚科技有限公司 Application of traditional Chinese medicine composition in preparation of medicines for treating nasosinusitis combined with facial pain
CN104815235A (en) * 2015-05-26 2015-08-05 合肥丰瑞隆生物科技有限公司 Traditional Chinese medicine for treating rhinitis
CN105902630A (en) * 2016-06-03 2016-08-31 王玉玲 Pharmaceutical composition for treating rhinitis and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524100A (en) * 2014-12-11 2015-04-22 广东聚智诚科技有限公司 Application of traditional Chinese medicine composition in preparation of medicines for treating nasosinusitis combined with facial pain
CN104815235A (en) * 2015-05-26 2015-08-05 合肥丰瑞隆生物科技有限公司 Traditional Chinese medicine for treating rhinitis
CN105902630A (en) * 2016-06-03 2016-08-31 王玉玲 Pharmaceutical composition for treating rhinitis and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101461911B (en) Chinese medicine oral capsule for treating gout
CN102973862B (en) Chinese medicine preparation for treating skin itch
CN104352587A (en) Ointment for treating rhinitis
CN103381266B (en) Traditional Chinese medicine for treating nervous vomiting
CN102225116A (en) Medicine for treating rhinitis and preparation method thereof
CN102274334A (en) Medicine for treating rhinitis and preparation method thereof
CN101966295A (en) Medicament for treating chronic amygdalitis
CN101239107A (en) Chinese medicine capsule for treating hemifacial spasm
CN103341063B (en) Chinese medicine composition for treating wind-heat cough
CN102805830A (en) Traditional Chinese medicine composite for treating acne
CN102406870B (en) Medicament for treating rheumatic arthralgia
CN104958627A (en) Traditional Chinese medicine for treating rhinitis
CN101028383A (en) Oral Chinese medicinal composition for treating acute nasosinusitis
CN106491887A (en) A kind of neck waist health rehabilitation paste and preparation method thereof
CN103127320B (en) Itching relieving and anti-allergic Chinese medicinal compound umbilical patch
CN102670919A (en) Chinese medicament for treating chronic pyelonephritis
CN102370853A (en) Traditional Chinese medicine for treating chronic pyelonephritis
CN102727675B (en) Traditional Chinese medicine capsules used for treating nasal sinusitis
CN1261123C (en) Chinese medicine preparation pus drawing out plaster for treating pasteur cystic, furuncle, furunculosis and carbuncle
CN102048871A (en) Formula of traditional Chinese medicine for treating renal calculus
CN101380414B (en) Traditional Chinese medicine composition for treating gout and hyperuricemia and preparation method thereof
CN103989801A (en) Rhinitis treatment decoction
CN104873862A (en) Traditional Chinese medicine composition for treating chronic pharyngitis
CN103285199B (en) Traditional Chinese medicine wine for treating lumbocrural pain and preparation method of traditional Chinese medicine wine
CN104666824A (en) Traditional Chinese medicinal composition for treating psoriasis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20111214